NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

表纸
市场调查报告书

前临床开采内脏器官灌流系统的市场规模:各类型、终端用户、地区 - 占有率,预测,及机会分析(2020年~2027年)

Preclinical Isolated Organ Perfusion System Market, by Type, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品编码 980035
出版日期 内容资讯 英文 198 Pages
商品交期: 2-3个工作天内
价格
前临床开采内脏器官灌流系统的市场规模:各类型、终端用户、地区 - 占有率,预测,及机会分析(2020年~2027年) Preclinical Isolated Organ Perfusion System Market, by Type, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年12月29日内容资讯: 英文 198 Pages
简介

全球前临床开采内脏器官灌流系统市场成长的促进因素,是器官移植数量的增加。依据非营利科学教育机关的United Network for Organ Sharing发表的记事,2016年美国进行33,600件器官移植,114,756个患者在候补名单上。

本报告提供全球前临床开采内脏器官灌流系统市场的相关调查,市场规模和占有率,机会和趋势,成长及阻碍因素,各类型、终端用户、地区的市场分析,竞争情形,主要企业的简介等资讯。

目录

第1章 调查目的、前提条件

第2章 市场展望

  • 报告概要
    • 市场定义和范围
  • 摘要整理
    • 市场明细:各类型
    • 市场明细:各终端用户
    • 市场明细:各地区
  • Coherent Opportunity Map (COM)

第3章 市场动态,法规,及趋势分析

  • 市场动态
    • 成长要素
    • 阻碍因素
    • 市场机会
  • 影响分析
  • 开发平台分析
  • 偿付方案
  • 流行病学
  • PEST分析
  • 法规方案
  • 新产品的销售
  • 合作与契约
  • 市场趋势

第4章 COVID-19大流行的影响

  • COVID-19市场方案
  • COVID-19市场对产品的影响

第5章 市场分析:各类型(2016-2027)

  • 简介
  • 开采心脏灌流
  • 开采腹部内脏器官灌流
  • 开采肺灌流
  • 其他

第6章 市场分析:各终端用户(2016-2027)

  • 简介
  • 产业研究所和CRO
  • 学术、政府研究机关

第7章 市场分析:各地区(2016-2027)

  • 简介
  • 北美
  • 南美
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第8章 竞争情形

  • 热图分析
  • 市场占有率分析
    • World Precision Instruments Inc.
    • Radnoti LLC
    • MDE GmbH
    • Harvard Bioscience Inc.
    • emka TECHNOLOGIES SAS
    • Danish Myo Technology AS
    • ADInstruments Pty Ltd.
    • Experimetria Ltd.

第9章 分析师的见解

第10章 Section

目录

Title:
Preclinical Isolated Organ Perfusion System Market, by Type (Isolated Heart Perfusion Systems, Isolated Abdominal Organ Perfusion Systems, Isolated Lung Perfusion Systems and Others), by End User (Industrial Laboratories and CROs and Academic and Government Research Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Isolated organ perfusion is an excellent tool for investigating the physiology and function of a variety of individual organs. It enables exploration of organs and their pharmacologic reactions. Isolated perfusion helps to understand the hemodynamics, effects of various perfusates, and toxicity of drugs on individual organs.

Market Dynamics

An increasing number of organ transplants is expected to drive the global preclinical isolated organ perfusion system market growth. For instance, according to an article published by the United Network for Organ Sharing, a non-profit, scientific and educational organization, in 2016, 33,600 organ transplants were performed in the U.S. and 114,756 patients were on the waiting list.

Key features of the study:

  • This report provides in-depth analysis of the global preclinical isolated organ perfusion system market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global preclinical isolated organ perfusion system market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study are World Precision Instruments Inc., Radnoti LLC, MDE GmbH, Harvard Bioscience Inc., emka TECHNOLOGIES S.A.S., Danish Myo Technology AS, ADInstruments Pty Ltd. and Experimetria Ltd. among others.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
  • The global preclinical isolated organ perfusion system market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preclinical isolated organ perfusion system market.

Detailed Segmentation:

  • Global Preclinical Isolated Organ Perfusion System Market, By Type:
    • Isolated Heart Perfusion Systems
    • Isolated Abdominal Organ Perfusion Systems
    • Isolated Lung Perfusion Systems
    • Others
  • Global Preclinical Isolated Organ Perfusion System Market, By End User:
    • Industrial Laboratories and CROs
    • Academic and Government Research Institutes
  • Global Preclinical Isolated Organ Perfusion System Market, By Region:
    • North America
      • By Type:
      • Isolated Heart Perfusion Systems
      • Isolated Abdominal Organ Perfusion Systems
      • Isolated Lung Perfusion Systems
      • Others
      • By End User:
      • Industrial Laboratories and CROs
      • Academic and Government Research Institutes
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Type:
      • Isolated Heart Perfusion Systems
      • Isolated Abdominal Organ Perfusion Systems
      • Isolated Lung Perfusion Systems
      • Others
      • By End User:
      • Industrial Laboratories and CROs
      • Academic and Government Research Institutes
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Type:
      • Isolated Heart Perfusion Systems
      • Isolated Abdominal Organ Perfusion Systems
      • Isolated Lung Perfusion Systems
      • Others
      • By End User:
      • Industrial Laboratories and CROs
      • Academic and Government Research Institutes
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Type:
      • Isolated Heart Perfusion Systems
      • Isolated Abdominal Organ Perfusion Systems
      • Isolated Lung Perfusion Systems
      • Others
      • By End User:
      • Industrial Laboratories and CROs
      • Academic and Government Research Institutes
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Type:
      • Isolated Heart Perfusion Systems
      • Isolated Abdominal Organ Perfusion Systems
      • Isolated Lung Perfusion Systems
      • Others
      • By End User:
      • Industrial Laboratories and CROs
      • Academic and Government Research Institutes
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Type:
      • Isolated Heart Perfusion Systems
      • Isolated Abdominal Organ Perfusion Systems
      • Isolated Lung Perfusion Systems
      • Others
      • By End User:
      • Industrial Laboratories and CROs
      • Academic and Government Research Institutes
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • World Precision Instruments Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Radnoti LLC
    • MDE GmbH
    • Harvard Bioscience Inc.
    • emka TECHNOLOGIES S.A.S.
    • Danish Myo Technology AS
    • ADInstruments Pty Ltd.
    • Experimetria Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • Reimbursement Scenario
  • Epidemiology
  • Pest Analysis
  • Regulatory Scenario
  • New Product Launches
  • Collaborations and Agreements
  • Market Trends

4. Global Preclinical Isolated Organ Perfusion System Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Market Scenario
  • Impact of COVID-19 Market on the Preclinical Isolated Organ Perfusion System Products

5. Global Preclinical Isolated Organ Perfusion System Market, By Type, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Isolated Heart Perfusion Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Isolated Abdominal Organ Perfusion Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Isolated Lung Perfusion Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Preclinical Isolated Organ Perfusion System Market, By End User, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Industrial Laboratories and CROs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Academic and Government Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global Preclinical Isolated Organ Perfusion System Market, By Region, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2027
  • North America
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • World Precision Instruments Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Radnoti LLC
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • MDE GmbH
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Harvard Bioscience Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • emka TECHNOLOGIES S.A.S.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Danish Myo Technology AS
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • ADInstruments Pty Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Experimetria Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

9. Analyst Views

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact